Arecoline increases basic fibroblast growth factor but reduces expression of IL-1, IL-6, G-CSF and GM-CSF in human umbilical vein endothelium

Journal of Oral Pathology and Medicine

Volumn 44, Issue 8, 2015, Pages 591-601

  Ullah, Mafaz ^a   Cox, Stephen ^a   Kelly, Elizabeth ^a   Moore, Malcolm A S ^b   Zoellner, Hans ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Arecoline; Cytokine; Endothelium; Fibroblast growth factor

Indexed keywords

ACETYLCHOLINE; ARECOLINE; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MUSCARINE; NICOTINE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IL6 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; NECROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; FIBROBLAST; GENETICS; METABOLISM; PROCEDURES; UMBILICAL VEIN;

ACETYLCHOLINE; ARECOLINE; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MUSCARINE; NICOTINE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 84940589844     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12276     Document Type: Article

References (66)

1. Winstock A. Areca nut-abuse liability, dependence and public health. Addict Biol 2002; 7: 133-8.
2. Gupta P, Warnakulasuriya S. Global epidemiology of areca nut usage. Addict Biol 2002; 7: 77-83.
3. Iarc. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2004; 85: 1-334.
4. Bhonsle RB, Murti PR, Daftary DK, et al. Regional variations in oral submucous fibrosis in India. Commun Dent Oral Epidemiol 1987; 15: 225-9.
5. Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 2001; 37: 477-92.
6. Trivedy C, Craig G, Warnakulasuriya S. The oral health consequences of chewing areca nut. Addict Biol 2002; 7: 115-25.
7. Pindborg JJ. Oral submucous fibrosis: a review. Ann Acad Med Singapore 1989; 18: 603-7.
8. Cox S, Zoellner H. Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. J Oral Pathol Med 2009; 38: 220-6.
9. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 2006; 42: 561-8.
10. Chang MC, Wu HL, Lee JJ, et al. The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. J Biol Chem 2004; 279: 50676-83.
11. Jeng JH, Hahn LJ, Lin BR, Hsieh CC, Chan CP, Chang MC. Effects of areca nut, inflorescence piper betle extracts and arecoline on cytotoxicity, total and unscheduled DNA synthesis in cultured gingival keratinocytes. J Oral Pathol Med 1999; 28: 64-71.
12. Harvey W, Scutt A, Meghji S, Canniff JP. Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol 1986; 31: 45-9.
13. Tsai CL, Kuo MY, Hahn LJ, Kuo YS, Yang PJ, Jeng JH. Cytotoxic and cytostatic effects of arecoline on oral mucosal fibroblasts. Proc Natl Sci Counc Repub China B 1997; 21: 161-7.
14. Sundqvist K, Liu Y, Erhardt P, Nair J, Bartsch H, Grafstrom RC. Areca-nut toxicity in cultured human buccal epithelial cells. IARC Sci Publ 1991; 105: 281-5.
15. Chang YC, Tai KW, Cheng MH, Chou LSS, Chou MY. Cytotoxic and non-genotoxic effects of arecoline on human buccal fibroblasts in vitro. J Oral Pathol Med 1998; 27: 68-71.
16. Cox S, Vickers ER, Ghu S, Zoellner H. Salivary arecoline levels during areca nut chewing in human volunteers. J Oral Pathol Med 2010; 39: 465-9.
17. Nair J, Ohshima H, Friesen M, Croisy A, Bhide S, Bartsch H. Tobacco-specific and betel nut-specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis 1985; 6: 295-303.
18. Sirsat SM, Pindborg JJ. The vascular response in early and advanced oral submucous fibrosis. Acta Pathol Microbiol Scand 1967; 70: 179-84.
19. Manjunath K, Rajaram PC, Saraswathi TR, et al. Evaluation of oral submucous fibrosis using ultrasonographic technique: a new diagnostic tool. Indian J Dent Res 2011; 22: 530-6.
20. Zoellner H, Hunter N. Perivascular hyaline deposits in inflamed gingival tissues. J Oral Pathol Med 1989; 18: 333-8.
21. Bolitho C, Bayl P, Hou JY, et al. The anti-apoptotic activity of albumin for endothelium is mediated by a partially cryptic protein domain and reduced by inhibitors of G-coupled protein and PI-3 kinase, but is independent of radical scavenging or bound lipid. J Vasc Res 2007; 44: 313-24.
22. Zoellner H, Hunter N. Vascular expansion in chronic periodontitis. J Oral Pathol Med 1991; 20: 433-7.
23. Bolitho C, Xaymardan M, Lynch GW, Zoellner H. Vascularity during wound maturation correlates with fragmentation of serum albumin but not ceruloplasmin, transferrin, or haptoglobin. Wound Repair Regen 2010; 18: 211-22.
24. Ullah M, Cox S, Kelly E, Boadle R, Zoellner H. Arecoline is cytotoxic for human endothelial cells. J Oral Pathol Med 2014; 43: 761-9.
25. Kuo FC, Wu DC, Yuan SSF, et al. Effects of arecoline in relaxing human umbilical vessels and inhibiting endothelial cell growth. J Perinat Med 2005; 33: 399-405.
26. Denton CP, Abraham DJ. Transforming growth factor-[beta] and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr Opin Rheumatol 2001; 13: 505-11.
27. Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma: collagen. Rheum Dis Clin North Am 1996; 22: 647-74.
28. Haque MF, Harris M, Meghji S, Barrett AW. Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine 1998; 10: 713-9.
29. Bishen KA, Radhakrishnan R, Satyamoorthy K. The role of basic fibroblast growth factor in oral submucous fibrosis pathogenesis. J Oral Pathol Med 2008; 37: 402-11.
30. Yu CD, Wang F, Jin CL, et al. Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis. Am J Pathol 2003; 163: 1653-62.
31. Powers C, Mcleskey S, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000; 7: 165-97.
32. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997; 18: 26-45.
33. Chu-Huang C, Poucher SM, Jonathan L, Henry PD. Fibroblast growth factor 2: from laboratory evidence to clinical application. Curr Vasc Pharmacol 2004; 2: 33-43.
34. Dow JK, Devere White RW. Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions. Urology 2000; 55: 800-6.
35. Inoue Y, King TE Jr, Barker E, Daniloff E, Newman LS. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med 2002; 166: 765-73.
36. Lawrence A, Khanna D, Misra R, Aggarwal A. Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis. Dermatol Online J 2006; 12: 2.
37. Makino T, Jinnin M, Muchemwa F, et al. Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways. Br J Dermatol 2010; 162: 717-23.
38. Montesano R, Vassalli J-D, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 1986; 83: 7297-301.
39. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989; 58: 575-606.
40. Klagsbrun M, Edelman ER. Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. Arteriosclerosis 1989; 9: 269-78.
41. Chujo S, Shirasaki F, Kondo-Miyazaki M, Ikawa Y, Takehara K. Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis. J Cell Physiol 2009; 220: 189-95.
42. Bolitho C, Xu W, Zoellner H. Negative feedback for endothelial apoptosis: a potential physiological role for fibroblast growth factor. J Vasc Res 2008; 45: 193-204.
43. Zoellner H, Cebon J, Layton JE, Stanton H, Hamilton JA. Contrasting effects of interleukin-4 on colony-stimulating factor and interleukin-6 synthesis by vascular endothelial cells. Lymphokine Cytokine Res 1993; 12: 93-9.
44. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745.
45. Zoellner H, Bielek E, Vanyek E, et al. Canalicular fragmentation of apoptotic human endothelial cells. Endothelium 1996; 4: 177-88.
46. Xu W, Boadle R, Dear L, Cvejic M, Emmanuel C, Zoellner H. Ultrastructural changes in endothelium during apoptosis indicate low microembolic potential. J Vasc Res 2005; 42: 377-87.
47. Jaffe EA, Hoyer LW, Nachman RL. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1973; 52: 2757-64.
48. Holthofer H, Virtanen I, Kariniemi AL, Hormia M, Linder E, Miettinen A. Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest 1982; 47: 60-6.
49. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 2001; 25: 402-8.
50. Zoellner H, Filonzi EL, Stanton HR, Layton JE, Hamilton JA. Human arterial smooth muscle cells synthesize granulocyte colony-stimulating factor in response to interleukin-1 alpha and tumor necrosis factor-alpha. Blood 1992; 80: 2805-10.
51. Gajdusek CM, Carbon S. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium. J Cell Physiol 1989; 139: 570-9.
52. Abraham JA, Mergia A, Whang JL, et al. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 1986; 233: 545-8.
53. Mcneil PL, Muthukrishnan L, Warder E, D'amore PA. Growth factors are released by mechanically wounded endothelial cells. J Cell Biol 1989; 109: 811-22.
54. Karsan A, Yee E, Poirier GG, Zhou P, Craig R, Harlan JM. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am J Pathol 1997; 151: 1775-84.
55. Fox JC, Shanley JR. Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J Biol Chem 1996; 271: 12578-84.
56. Araki S, Shimada Y, Kaji K, Hayashi H. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun 1990; 168: 1194-200.
57. Lee KK, Choi JD. The effects of areca catechu l extract on anti-inflammation and anti-melanogenesis. Int J Cosmet Sci 1999; 21: 275-84.
58. Huang LW, Hsieh BS, Cheng HL, Hu YC, Chang WT, Chang KL. Arecoline decreases interleukin-6 production and induces apoptosis and cell cycle arrest in human basal cell carcinoma cells. Toxicol Appl Pharmacol 2012; 258: 199-207.
59. Bhandare AM, Kshirsagar AD, Vyawahare NS, Hadambar AA, Thorve VS. Potential analgesic, anti-inflammatory and antioxidant activities of hydroalcoholic extract of areca catechu nut. Food Chem Toxicol 2010; 48: 3412-7.
60. Haque MF, Meghji S, Khitab U, Harris M. Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med 2000; 29: 123-8.
61. Haque MF, Meghji S, Nazir R, Harris M. Interferon gamma (IFN-gamma) may reverse oral submucous fibrosis. J Oral Pathol Med 2001; 30: 12-21.
62. Tsai CH, Yang SF, Chen YJ, Chu SC, Hsieh YS, Chang YC. Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels. Oral Dis 2004; 10: 360-4.
63. Chiang SL, Jiang SS, Wang YJ, et al. Characterization of arecoline-induced effects on cytotoxicity in normal human gingival fibroblasts by global gene expression profiling. Toxicol Sci 2007; 100: 66-74.
64. Kuo PL, Hsu YL, Huang MS, Chiang SL, Ko YC. Bronchial epithelium-derived IL-8 and RANTES increased bronchial smooth muscle cell migration and proliferation by Kruppel-like factor 5 in areca nut-mediated airway remodeling. Toxicol Sci 2011; 121: 177-90.
65. Zhao RJ, Pan ZY, Long CL, Cui WY, Zhang YF, Wang H. Stimulation of non-neuronal muscarinic receptors enhances chemerin/ChemR23 system in dysfunctional endothelial cells. Life Sci 2012; 92: 10-16.
66. Shan L-M, Zhang J-C, Zhao Y-L, Cui W-Y, Wang H. Molecular mechanisms for arecoline against atherosclerosis. Chin Pharmacol Bull 2004; 20: 146-50.